China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 January 2025, Volume 35 Issue 1 Previous Issue Next Issue

Cover and contents

2025 Issue 1 Cover

Abstract ( 117) PDF (753KB) ( 108 )

Contents of Issue 1, 2025

2025, 35 (1): 2-2.

Abstract ( 61) PDF (10546KB) ( 42 )

Specialist' Commentary

New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024

WANG Ting, QIN Yi, XU Xiaowu, YU Xianjun

2025, 35 (1): 1-11. doi: 10.19401/j.cnki.1007-3639.2025.01.001

Abstract ( 392) PDF (1078KB) ( 646 ) HTML ( 17 )

Current status and prospect of diagnosis and treatment of bone metastasis of thyroid cancer

ZHAO Yihan, LI Ruochen, LIN Yansong

2025, 35 (1): 12-20. doi: 10.19401/j.cnki.1007-3639.2025.01.002

Abstract ( 144) PDF (1151KB) ( 325 ) HTML ( 7 )

Research progress in epidemiology and risk factors of thyroid cancer

ZHANG Zhiyue, HE Huijing, SHAN Guangliang, LIN Yansong

2025, 35 (1): 21-29. doi: 10.19401/j.cnki.1007-3639.2025.01.003

Abstract ( 222) PDF (1092KB) ( 355 ) HTML ( 14 )

Progress and prospect on treatment for radioiodine-refractory thyroid cancer

GENG Qianqian, YANG Aimin

2025, 35 (1): 30-39. doi: 10.19401/j.cnki.1007-3639.2025.01.004

Abstract ( 120) PDF (1074KB) ( 289 ) HTML ( 7 )

Current status and future prospects of clinical trials for radioiodine-refractory thyroid cancer

LI Ruping, YANG Hui

2025, 35 (1): 40-48. doi: 10.19401/j.cnki.1007-3639.2025.01.005

Abstract ( 110) PDF (1077KB) ( 242 ) HTML ( 4 )

The unique value and controversy of nuclear medicine molecular imaging in the evaluation of radioiodine-refractory differentiated thyroid cancer

WANG Renfei, LU Gaixia

2025, 35 (1): 49-57. doi: 10.19401/j.cnki.1007-3639.2025.01.006

Abstract ( 102) PDF (1374KB) ( 272 ) HTML ( 1 )

Application and prospect of targeted therapy and immunotherapy in radioiodine-refractory differentiated thyroid cancer

LIN Qiuyu, WANG Yuxin, LIN Chenghe

2025, 35 (1): 58-67. doi: 10.19401/j.cnki.1007-3639.2025.01.007

Abstract ( 101) PDF (1135KB) ( 258 ) HTML ( 2 )

Specialist' Article

Survival and cause-of-death analysis of 55 thousand thyroid cancer cases in China from a large single institution hospital-based cancer registry database

SHEN Jie, LIU Wanlin, WANG Zezhou, MU Sibo, MO Miao, ZHOU Changming, YUAN Jing, WANG Yu, ZHENG Ying, JI Qinghai

2025, 35 (1): 68-76. doi: 10.19401/j.cnki.1007-3639.2025.01.008

Abstract ( 139) PDF (1256KB) ( 153 ) HTML ( 8 )

The role of diagnostic whole body scan in decision-making of ¹³¹I treatment for differentiated thyroid cancer

JIANG Xiaotong, LIU Jinchuan, ZHANG Yingqiang, WANG Tong, GUO Ning, SUN Yuqing, SHI Cong, YAN Bing, LIN Yansong

2025, 35 (1): 77-84. doi: 10.19401/j.cnki.1007-3639.2025.01.009

Abstract ( 103) PDF (1478KB) ( 133 ) HTML ( 7 )

Guideline and Concensus

China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition)

Society of Neuroendocrine Neoplasm of China Anti-Cancer Association

2025, 35 (1): 85-142. doi: 10.19401/j.cnki.1007-3639.2025.01.010

Abstract ( 599) PDF (1479KB) ( 725 ) HTML ( 17 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat